Remove Academic Remove Cerebrovascular Disease Remove Certification
article thumbnail

CorVascular’s VasoGuard Earns FDA 510(k) Clearance

DAIC

Early identification allows for timely initiation of guideline-directed medical therapy for secondary prevention of cardiovascular disease, cerebrovascular disease, and limb events. It has been over a decade since anything new has come to this market and the VasoGuard is a perfect fit; the right line at the right time.”